Search Results 71-80 of 8787 for narcolepsy
People with narcolepsy experience overwhelming daytime drowsiness. They can fall asleep suddenly. REM sleep behavior disorder. This sleep disorder involves ...
The purpose of this study is to evaluate the efficacy and safety of TAK-861 in people with narcolepsy type 1 (NT1). Participation eligibility. Participant ...
Narcolepsy is uncontrollable desire for sleep or a sudden attack of deep sleep. Cataplexy is a sudden onset of muscle weakness. This medicine is available only ...
This program will be open to adult patients in the U.S. with Excessive Daytime Sleepiness (EDS) associated with narcolepsy, with or without cataplexy.
The main aim is to evaluate the safety and tolerability of TAK-861 on participants with type 1 narcolepsy, who were exposed to previously tested doses of TAK- ...
Clinical Trials · A Study To Evaluate The Efficacy And Safety Of ALKS 2680 In Adults With Narcolepsy Type 1 · More about research at Mayo Clinic · Mayo Clinic ...
Clinical Trials · A Study To Evaluate The Efficacy And Safety Of ALKS 2680 In Adults With Narcolepsy Type 2 · More about research at Mayo Clinic · Mayo Clinic ...
Dextroamphetamine is used to treat attention-deficit hyperactivity disorder (ADHD) and narcolepsy (sleep disorder). It belongs to the group of medicines ...
The purpose of this study is to assess the safety and efficacy of AXS-12 in narcoleptic subjects with cataplexy and excessive daytime sleepiness (EDS).
Narcolepsy · Night leg cramps · Nightmare disorder; Nocturnal epilepsy; Non 24-hour wake-sleep disorder; Obstructive sleep apnea; Parasomnia; Pediatric ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.